AMEX:CLDI (USA)
Â
Ordinary Shares - Class A
$
0.16
+0.0007 (+0.44%)
10:08 PM EST
Business Description
Calidi Biotherapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US3207031010
Share Class Description:
CLDI: Ordinary Shares - Class ADescription
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | -0.82 | |||||
| Debt-to-Equity | -0.88 | |||||
| Debt-to-EBITDA | -0.78 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -95.5 | |||||
| 3-Year EPS without NRI Growth Rate | -97.4 | |||||
| 3-Year FCF Growth Rate | -124.6 | |||||
| 3-Year Book Growth Rate | 28.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.41 | |||||
| 9-Day RSI | 28.01 | |||||
| 14-Day RSI | 31.59 | |||||
| 6-1 Month Momentum % | -77.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.42 | |||||
| Quick Ratio | 0.42 | |||||
| Cash Ratio | 0.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.4 | |||||
| Shareholder Yield % | -66.04 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -99.11 | |||||
| ROIC % | -53.13 | |||||
| ROC (Joel Greenblatt) % | -220.14 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.35 | |||||
| EV-to-Forward-EBIT | -0.83 | |||||
| EV-to-EBITDA | -1.41 | |||||
| EV-to-FCF | -0.48 | |||||
| Earnings Yield (Greenblatt) % | -74.07 | |||||
| FCF Yield % | -350.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:CLDI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Calidi Biotherapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.372 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 31.59 | ||
| 14-Day ATR ($) | 0.101114 | ||
| 20-Day SMA ($) | 0.370315 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.1435 - 5 | ||
| Shares Outstanding (Mil) | 48.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Calidi Biotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Calidi Biotherapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Calidi Biotherapeutics Inc Frequently Asked Questions
What is Calidi Biotherapeutics Inc(CLDI)'s stock price today?
The current price of CLDI is $0.16. The 52 week high of CLDI is $5.00 and 52 week low is $0.14.
When is next earnings date of Calidi Biotherapeutics Inc(CLDI)?
The next earnings date of Calidi Biotherapeutics Inc(CLDI) is 2024-05-31 Est..
Does Calidi Biotherapeutics Inc(CLDI) pay dividends? If so, how much?
Calidi Biotherapeutics Inc(CLDI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers